Bayer mediator dismisses report of $8 billion Roundup settlement
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said,…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to the U.S. health regulator regarding an ongoing study of the…
Patient groups push back against Gilead’s pricey HIV prevention treatment
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker…
Nobio gets FDA approval for anti-bacterial dental fillings
TEL AVIV (Reuters) – Israel’s Nobio Ltd said on Monday it received approval from the U.S. Food and Drug Administration to market its anti-bacterial composite designed to remain in the…
Only one in six U.S. universities are smoke-free
(Reuters Health) – Universities across the United States have been slow to adopt anti-tobacco policies on campuses, researchers say, despite public health efforts to curb tobacco use, especially among teens…
Measles surveillance lags in U.S. workplaces, expert says
(Reuters Health) – – Monitoring for measles in U.S. workplaces needs improvement, especially in the healthcare sector, an occupational safety expert argues. FILE PHOTO: A vial of the measles, mumps,…
Oklahoma makes final bid to hold J&J responsible for opioid epidemic
(Reuters) – Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion for its part in fueling the opioid epidemic, saying the…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel on Friday for use as an additional treatment…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in Europe to tackle tumours with a specific genetic mutation regardless…
In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million
(Reuters) – A California judge on Thursday reduced a $2 billion jury verdict, slashing the award for a couple who blamed Bayer AG’s glyphosate-based weed killer, Roundup, for their cancer…